Mutations of the ApoB and MTP, such as in familial hypobetalipoproteinemia [64] and abetalipoproteinemia [65], respectively, can increase the risk of NAFLD by impaired TG secretions, such as VLDL. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.